The presence of p53 mutations in human osteosarcomas correlates with high levels of genomic instability
AUTOR(ES)
Overholtzer, Michael
FONTE
National Academy of Sciences
RESUMO
The p53 gene is a critical tumor suppressor that is inactivated in a majority of cancers. The central role of p53 in response to stresses such as DNA damage, hypoxia, and oncogene activation underlies this high frequency of negative selection during tumorigenic transformation. Mutations in p53 disrupt checkpoint responses to DNA damage and result in the potential for destabilization of the genome. Consistent with this, p53 mutant cells have been shown to accumulate genomic alterations in cell culture, mouse models, and some human tumors. The relationship between p53 mutation and genomic instability in human osteosarcoma is addressed in this report. Similar to some other primary human tumors, the mutation of p53 correlates significantly with the presence of high levels of genomic instability in osteosarcomas. Surprisingly, osteosarcomas harboring an amplification of the HDM2 oncogene, which inhibits the tumor-suppressive properties of p53, do not display high levels of genomic instability. These results demonstrate that the inactivation of p53 in osteosarcomas directly by mutation versus indirectly by HDM2 amplification may have different cellular consequences with respect to the stability of the genome.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=208795Documentos Relacionados
- Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein.
- High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas.
- Association of p53 genomic instability with the glutathione S-transferase null genotype in gastric cancer in the Portuguese population.
- p53 functions as a cell cycle control protein in osteosarcomas.
- Human tumor p53 mutations are selected for in mouse embryonic fibroblasts harboring a humanized p53 gene